All products / DC23168
CCT128930
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $450 USDRequest a quote / confirm availability → |
| 250 mg | $900 USDRequest a quote / confirm availability → |
| 1 g | $1,800 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
CCT128930 is a potent, selective, ATP-competitive AKT inhibitor with IC50 of 6 nM (AKT2), 28-fold selectivity over the closely related PKA; also exhibits 20-fold selectivity over p70S6K (IC50=120 nM); shows growth inhibition for U87MG human glioblastoma cells (IC50=6.3 uM), for LNCaP human prostate cancer cells (IC50=0.35 uM), and for PC3 human prostate cancer cells (IC50=1.9 uM) consistent with AKT pathway blockade; blocks the phosphorylation of several downstream AKT biomarkers in U87MG tumor xenografts, indicating AKT inhibition in vivo; demonstrates antitumor activity in U87MG and HER2-positive, PIK3CA-mutant BT474 human breast cancer xenografts.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC23168 |
|---|---|
| Product name | CCT128930 |
| CAS | 885499-61-6 |
| Molecular formula | C18H20ClN5 |
| Molecular weight | 341.837902069092 |
| Purity | >98% |
| SMILES | NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — CCT128930 (DC23168)